Are employees ready to engage in genetic cancer risk assessment in the workplace setting?-Reference-Cited by-同舟云学术

Are employees ready to engage in genetic cancer risk assessment in the workplace setting?

Published:2024-07-23 Issue: Volume: Page:
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Chandler Isabelle R.^ORCID,Brewer Jesse T.^ORCID,Ahsan Muhammad Danyal^ORCID,Soussana Tamar Nicole,Webster Emily M.,Primiano Michelle,Sharaf Ravi N.,Frey Melissa K.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41431-024-01655-2.pdf

Reference10 articles.

1. National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 2.2024). NCCN Clinical Practice Guidelines in Oncology. 2024 https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf.

2. Sessa C, Balmana J, Bober SL, Cardoso MJ, Colombo N, Curigliano G, et al. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol. 2023;34:33–47.

3. Webster EM, Ahsan MD, McDougale A, Sharaf RN, Frey MK. Implementation of a smartphone survey and mainstreaming for genetic cancer risk assessment in a diverse, urban Medicaid-predominant gynecology clinic: A step towards health equity. Am J Obstet Gynecol. 2024;230:e108–e109.

4. Drohan B, Roche CA, Cusack JC Jr, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012;19:1732–7.

5. Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg. 2016;212:660–9.